Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer's Disease: Role of CCL2. Alzforum, 19 Jul 2019 Gutiérrez IL, González-Prieto M, Caso JR, García-Bueno B, Leza JC, Madrigal JL.